NCT03986671View on ClinicalTrials.gov

Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

March 26, 2021

Study Completion Date

March 26, 2021

Conditions
Obstructive Sleep ApneaAmyotrophic Lateral SclerosisMuscular DystrophiesHealthy
Interventions
DEVICE

Transmembrane EMG Oropharynx Probe

Examination of the electromyographic signal from oropharyngeal muscles obtained using an investigational transmembrane sensor attached to a rigid probe and an FDA-approved very fine concentric needle electrode (Ambu Neuroline 25 mm x 30G).

Trial Locations (1)

92108

SENTA Clinic, San Diego

All Listed Sponsors
lead

Powell Mansfield Inc.

OTHER

NCT03986671 - Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx | Biotech Hunter | Biotech Hunter